Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update
HOUSTON, TX--(Marketwired - June 27, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based …